<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jdi13973" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Investig</journal-id><journal-id journal-id-type="iso-abbrev">J Diabetes Investig</journal-id><journal-id journal-id-type="pmc-domain-id">2358</journal-id><journal-id journal-id-type="pmc-domain">jdi</journal-id><journal-id journal-id-type="publisher-id">JDI</journal-id><journal-title-group><journal-title>Journal of Diabetes Investigation</journal-title></journal-title-group><issn pub-type="ppub">2040-1116</issn><issn pub-type="epub">2040-1124</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10034957</article-id><article-id pub-id-type="pmcid-ver">PMC10034957.1</article-id><article-id pub-id-type="pmcaid">10034957</article-id><article-id pub-id-type="pmcaiid">10034957</article-id><article-id pub-id-type="pmid">36789495</article-id><article-id pub-id-type="doi">10.1111/jdi.13973</article-id><article-id pub-id-type="publisher-id">JDI13973</article-id><article-id pub-id-type="other">JDI-OA-2022-0542.R2</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Articles</subject><subj-group subj-group-type="heading"><subject>Clinical Science and Care</subject></subj-group></subj-group></article-categories><title-group><article-title>Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM&#8208;Japan study</article-title><alt-title alt-title-type="right-running-head">Factors associated with HGI</alt-title><alt-title alt-title-type="left-running-head">Sakane <italic toggle="no">et al.</italic></alt-title></title-group><contrib-group><contrib id="jdi13973-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Sakane</surname><given-names initials="N">Naoki</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2625-571X</contrib-id><xref rid="jdi13973-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>nsakane@gf6.so-net.ne.jp</email></address></contrib><contrib id="jdi13973-cr-0002" contrib-type="author"><name name-style="western"><surname>Hirota</surname><given-names initials="Y">Yushi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3035-4155</contrib-id><xref rid="jdi13973-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jdi13973-cr-0003" contrib-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names initials="A">Akane</given-names></name><xref rid="jdi13973-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jdi13973-cr-0004" contrib-type="author"><name name-style="western"><surname>Miura</surname><given-names initials="J">Junnosuke</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5115-1111</contrib-id><xref rid="jdi13973-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jdi13973-cr-0005" contrib-type="author"><name name-style="western"><surname>Takaike</surname><given-names initials="H">Hiroko</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9531-2802</contrib-id><xref rid="jdi13973-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jdi13973-cr-0006" contrib-type="author"><name name-style="western"><surname>Hoshina</surname><given-names initials="S">Sari</given-names></name><xref rid="jdi13973-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jdi13973-cr-0007" contrib-type="author"><name name-style="western"><surname>Toyoda</surname><given-names initials="M">Masao</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4142-1218</contrib-id><xref rid="jdi13973-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jdi13973-cr-0008" contrib-type="author"><name name-style="western"><surname>Saito</surname><given-names initials="N">Nobumichi</given-names></name><xref rid="jdi13973-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jdi13973-cr-0009" contrib-type="author"><name name-style="western"><surname>Hosoda</surname><given-names initials="K">Kiminori</given-names></name><xref rid="jdi13973-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="jdi13973-cr-0010" contrib-type="author"><name name-style="western"><surname>Matsubara</surname><given-names initials="M">Masaki</given-names></name><xref rid="jdi13973-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="jdi13973-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="jdi13973-cr-0011" contrib-type="author"><name name-style="western"><surname>Tone</surname><given-names initials="A">Atsuhito</given-names></name><xref rid="jdi13973-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="jdi13973-cr-0012" contrib-type="author"><name name-style="western"><surname>Kawashima</surname><given-names initials="S">Satoshi</given-names></name><xref rid="jdi13973-aff-0008" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib id="jdi13973-cr-0013" contrib-type="author"><name name-style="western"><surname>Sawaki</surname><given-names initials="H">Hideaki</given-names></name><xref rid="jdi13973-aff-0009" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib id="jdi13973-cr-0014" contrib-type="author"><name name-style="western"><surname>Matsuda</surname><given-names initials="T">Tomokazu</given-names></name><xref rid="jdi13973-aff-0010" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib id="jdi13973-cr-0015" contrib-type="author"><name name-style="western"><surname>Domichi</surname><given-names initials="M">Masayuki</given-names></name><xref rid="jdi13973-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jdi13973-cr-0016" contrib-type="author"><name name-style="western"><surname>Suganuma</surname><given-names initials="A">Akiko</given-names></name><xref rid="jdi13973-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jdi13973-cr-0017" contrib-type="author"><name name-style="western"><surname>Sakane</surname><given-names initials="S">Seiko</given-names></name><xref rid="jdi13973-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jdi13973-cr-0018" contrib-type="author"><name name-style="western"><surname>Murata</surname><given-names initials="T">Takashi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8634-9657</contrib-id><xref rid="jdi13973-aff-0011" ref-type="aff">
<sup>11</sup>
</xref><xref rid="jdi13973-aff-0012" ref-type="aff">
<sup>12</sup>
</xref></contrib></contrib-group><aff id="jdi13973-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Division of Preventive Medicine, Clinical Research Institute</named-content>
<institution>National Hospital Organization Kyoto Medical Center</institution>
<city>Kyoto</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Division of Diabetes and Endocrinology, The&#160;Department of Internal Medicine</named-content>
<institution>Kobe University Graduate School of Medicine</institution>
<city>Hyogo</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Division of Diabetology and Metabolism, Department of Internal Medicine</named-content>
<institution>Tokyo Women's Medical University School of Medicine</institution>
<city>Tokyo</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine</named-content>
<institution>Tokai University School of Medicine</institution>
<city>Isehara</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Division of Diabetes and Lipid Metabolism</named-content>
<institution>National Cerebral and Cardiovascular Center</institution>
<city>Osaka</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of General Medicine</named-content>
<institution>Nara Medical University</institution>
<city>Nara</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>
<institution>Okayama Saiseikai General Hospital</institution>
<city>Okayama</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0008">
<label>
<sup>8</sup>
</label>
<institution>Kanda Naika Clinic</institution>
<city>Osaka</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0009">
<label>
<sup>9</sup>
</label>
<institution>Sawaki Internal Medicine and Diabetes Clinic</institution>
<city>Osaka</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0010">
<label>
<sup>10</sup>
</label>
<institution>Matsuda Diabetes Clinic</institution>
<city>Kobe</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0011">
<label>
<sup>11</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Nutrition</named-content>
<institution>National Hospital Organization Kyoto Medical Center</institution>
<city>Kyoto</city>
<country country="JP">Japan</country>
</aff><aff id="jdi13973-aff-0012">
<label>
<sup>12</sup>
</label>
<named-content content-type="organisation-division">Diabetes Center</named-content>
<institution>National Hospital Organization Kyoto Medical Center</institution>
<city>Kyoto</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Naoki Sakane<break/>
Tel.: +81&#8208;75&#8208;641&#8208;9161<break/>
Fax: +81&#8208;75&#8208;643&#8208;4325<break/>
E&#8208;mail address: <email>nsakane@gf6.so-net.ne.jp</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>2</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2023</year></pub-date><volume>14</volume><issue seq="120">4</issue><issue-id pub-id-type="pmc-issue-id">431912</issue-id><issue-id pub-id-type="doi">10.1111/jdi.v14.4</issue-id><fpage>582</fpage><lpage>590</lpage><history><date date-type="rev-recd"><day>22</day><month>12</month><year>2022</year></date><date date-type="received"><day>27</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>24</day><month>12</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>02</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>24</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-03-27 16:10:14.917"><day>27</day><month>03</month><year>2023</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2022 The Authors. <italic toggle="yes">Journal of Diabetes Investigation</italic> published by Asian Association for the Study of Diabetes (AASD) and John Wiley &amp; Sons Australia, Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JDI-14-582.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:JDI-14-582.pdf"/><abstract><title>ABSTRACT</title><sec id="jdi13973-sec-0001"><title>Aims/Introduction</title><p>The discrepancy between HbA1c and glucose exposure may have significant clinical implications; however, the association between the hemoglobin glycation index (HGI) and clinical parameters in type 1 diabetes remains controversial. This study aimed to find the factors associated with HGI (laboratory HbA1c &#8722; predicted HbA1c derived from the continuous glucose monitoring [CGM]).</p></sec><sec id="jdi13973-sec-0002"><title>Materials and Methods</title><p>We conducted a cross&#8208;sectional study of adults with type 1 diabetes (<italic toggle="no">n</italic>&#160;=&#160;211, age 50.9&#8201;&#177;&#8201;15.2&#8201;years old, female sex&#160;=&#160;59.2%, duration of CGM use&#160;=&#160;2.1&#8201;&#177;&#8201;1.0&#8201;years). All subjects wore the CGM for 90&#8201;days before HbA1c measurement. Data derived from the FreeStyle Libre sensor were used to calculate the glucose management indicator (GMI) and glycemic variability (GV) parameters. HGI was defined as the difference between the GMI and the laboratory HbA1c levels. The participants were divided into three groups according to the HGI tertile (low, moderate, and high). Multivariate regression analyses were performed.</p></sec><sec id="jdi13973-sec-0003"><title>Results</title><p>The female sex ratio, HbA1c, and % coefficient of variation (%CV) significantly increased over the HGI tertile, while eGFR and Hb decreased over the HGI tertile. In multivariate analysis, the factors associated with HGI were %CV and eGFR, after adjusting for HbA1c level and sex (<italic toggle="no">R</italic>
<sup>2</sup>&#160;=&#160;0.44).</p></sec><sec id="jdi13973-sec-0004"><title>Conclusions</title><p>This study demonstrated that HGI is associated with female sex, eGFR, and some glycemic variability indices, independently of HbA1c. Minimizing glycemic fluctuations might reduce HGI. This information provides diabetic health professionals and patients with personalized diabetes management for adults with type 1 diabetes.</p></sec></abstract><abstract abstract-type="graphical"><p>This study aimed to investigate factors associated with the hemoglobin glycation index (HGI) indicating a discrepancy between HbA1c and glucose exposure in adults with type 1 diabetes. Female sex ratio, HbA1c, and % coefficient of variation (%CV) significantly increased over the HGI tertile, while eGFR and Hb decreased over the HGI tertile. In multivariate analysis, the factors associated with HGI were %CV and eGFR, after adjusting for HbA1c level and sex (<italic toggle="no">R</italic>
<sup>2</sup>&#160;=&#160;0.44).<boxed-text position="anchor" content-type="graphic" id="jdi13973-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="JDI-14-582-g002.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jdi13973-kwd-0001">Continuous glucose monitoring</kwd><kwd id="jdi13973-kwd-0003">Glycated hemoglobin A1c</kwd><kwd id="jdi13973-kwd-0004">Glycemic variability</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Japan Agency for Medical Research and Development (AMED)
</institution><institution-id institution-id-type="doi">10.13039/100009619</institution-id></institution-wrap></funding-source><award-id>20ek0210104h0003</award-id><award-id>19ek0210104h0002</award-id><award-id>18ek0210104h0001</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="5"/><page-count count="590"/><word-count count="6613"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.6 mode:remove_FC converted:23.03.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jdi13973-ntgp-0001"><fn id="jdi13973-note-0001"><p>
<bold>Clinical Trial Registry</bold>
</p><p>
<italic toggle="yes">UMIN Clinical Trials Registry</italic>
</p><p>UMIN000039376</p></fn></fn-group></notes></front><body id="jdi13973-body-0001"><sec id="jdi13973-sec-0005"><title>INTRODUCTION</title><p>The hemoglobin A1c (A1c) test, which indicates the average blood glucose level over the past 90&#8201;days, is used to diagnose diabetes and to evaluate a patient's level of glycemic control<xref rid="jdi13973-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>. However, healthcare professionals often find a discrepancy between HbA1c and average blood glucose levels in routine clinical practice. The hemoglobin glycation index (HGI; laboratory A1c &#8211; predicted A1c) is a marker to quantify inter&#8208;individual variation in glycosylation of hemoglobin<xref rid="jdi13973-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>. In type 2 diabetes, a high HGI is associated with an increased risk of diabetic complications, cardiovascular disease, and mortality<xref rid="jdi13973-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="jdi13973-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="jdi13973-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="jdi13973-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jdi13973-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jdi13973-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jdi13973-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>. In a community&#8208;based survey, a high HGI was associated with an increased risk of arterial hypertension<xref rid="jdi13973-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>. This suggests that the HGI could be used clinically for a more personalized assessment of the risk of complications in type 1 diabetes<xref rid="jdi13973-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>. High glycation phenotypes in people with type 1 diabetes result in a challenge for the interpretation of better glycemic control<xref rid="jdi13973-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>. In people with type 1 diabetes, the association between clinical parameters and the HGI remains controversial<xref rid="jdi13973-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="jdi13973-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="jdi13973-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>. This mechanism is not fully understood. In non&#8208;diabetic people, the effects of inflammation on HbA1c were reflected by HGI<xref rid="jdi13973-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>. HGI was also associated with telomere attrition through TNF&#8208;&#945;<xref rid="jdi13973-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>. Therefore, understanding the discrepancy between glucose exposure and HbA1c levels might have some clinical implications in adults with type 1 diabetes. This study aimed to find the factors associated with HGI (laboratory HbA1c &#8722; predicted HbA1c derived from the continuous glucose monitoring [CGM]).</p></sec><sec sec-type="methods" id="jdi13973-sec-0006"><title>METHODS</title><sec id="jdi13973-sec-0007"><title>Study design</title><p>The FGM&#8208;Japan study is a cross&#8208;sectional study designed to evaluate the adherence to self&#8208;monitoring of blood glucose (SMBG) and the association of HGI with CGM metrics in adults with type 1 diabetes in a real&#8208;world setting in Japan. This study was approved by the Ethics Committee of the National Hospital Organization (NHO) Kyoto Medical Center (No. 19&#8208;072) and registered (UMIN000039376).</p></sec><sec id="jdi13973-sec-0008"><title>Participants</title><p>The participants were recruited from a collaborating center between February 2020 and March 2022. The inclusion criteria were the following: (1) type 1 diabetes, (2) &#8805;3&#8201;months duration of CGM use, (3) age &#8805;20&#8201;years, and (4) attendance at a collaborating NHO center. Exclusion criteria were as follows: (1) non&#8208;insulin therapy, (2) anti&#8208;dementia drug treatment, and (3) inappropriate cases judged by the research coordinators or director.</p></sec><sec id="jdi13973-sec-0009"><title>Measures</title><p>Continuous glucose monitoring metrics<xref rid="jdi13973-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="jdi13973-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="jdi13973-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, which were collected over the past 90&#8201;days of FreeStyle Libre (Abbott Diabetes Care Inc., Alameda, CA, USA), were calculated if the CGM data were adequate (&#8805;70%)<xref rid="jdi13973-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>. Severe hypoglycemia (SH) episodes in the preceding year, hypoglycemic episodes in the preceding month was recorded. Impaired awareness of hypoglycemia (IAH) was determined using the Gold questionnaire. Information on diabetic retinopathy, nephropathy<xref rid="jdi13973-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, and diabetic peripheral neuropathy (DPN)<xref rid="jdi13973-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> were collected. Diabetic retinopathy was assessed by an ophthalmologist using retinal photography. Retinopathy was classified as absent, simple, pre&#8208;proliferative, or proliferative. Nephropathy was classified as stage 1&#8211;5 based on the estimated glomerular filtration rate, the presence of albuminuria, or the hemodialysis stage. DPN was considered present following the criteria after the diagnosis of diabetes and excluding polyneuropathy, except for diabetic polyneuropathy; it was determined to be positive in the presence of at least two of the following three criteria: (1) subjective symptoms (numbness, pain, or dysesthesia in the bilateral lower extremities); (2) decreased or absent bilateral Achilles tendon reflexes; and (3) diminished bilateral vibratory sensation at the malleolus medialis (&lt;10&#8201;s using a tuning fork at 128&#8201;Hz). Laboratory data (glycemic markers, blood cell parameters<xref rid="jdi13973-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, liver enzyme levels, and lipids) were collected. Serum osmolarity<xref rid="jdi13973-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, glycated albumin (GA)/HbA1c ratio<xref rid="jdi13973-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>. G&#8208;gap<xref rid="jdi13973-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="jdi13973-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, neutrophil&#8208;to&#8208;lymphocyte ratio, platelet&#8208;to&#8208;lymphocyte ratio<xref rid="jdi13973-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, the fibrosis&#8208;4 index<xref rid="jdi13973-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> were calculated. Lifestyle factors were also collected using a questionnaire<xref rid="jdi13973-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>.</p></sec><sec id="jdi13973-sec-0010"><title>Statistical analysis</title><p>The hemoglobin glycation index (formula: laboratory HbA1c&#8201;&#8722;&#8201;predicted HbA1c derived from CGM) were divided into high, moderate, and low tertiles. We performed statistical analyses: Fisher's exact test, the Cochran&#8208;Armitage trend test, Student's <italic toggle="yes">t</italic>&#8208;test, Mann&#8211;Whitney U test, analysis of variance with Tukey's test, Kruskal&#8211;Wallis test, Jonckheere&#8208;Terpstra trend test, Pearson's correlation coefficient test, and linear regression analysis. Glycemic variability (GV) was calculated using gluvarpro and iglu R packages<xref rid="jdi13973-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="jdi13973-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>. Cases with missing data were excluded from the analysis. Statistical significance was set at <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05. The analysis was conducted using the R program version 4.1.2.</p></sec></sec><sec sec-type="results" id="jdi13973-sec-0011"><title>RESULTS</title><p>The study was conducted on 211 adults with type 1 diabetes (mean age, 50.9&#8201;&#177;&#8201;15.2&#8201;years; female, 59.2%; duration of CGM use, 2.1&#8201;&#177;&#8201;1.0&#8201;years). The participants were divided into three subgroups according to their HGI tertile (Table&#160;<xref rid="jdi13973-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="jdi13973-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Clinical characteristics of FGM&#8208;Japan participants by HGI tertile</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Variable</th><th colspan="3" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">HGI tertile</th><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">
<italic toggle="yes">P</italic> value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Low (&#8722;0.855 to 0.043)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Moderate (0.454&#8211;0.863)</th><th align="left" valign="bottom" rowspan="1" colspan="1">High (0.865&#8211;2.354)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="left" valign="top" rowspan="1" colspan="1">47.8 (15.4)</td><td align="left" valign="top" rowspan="1" colspan="1">52.4 (15.3)</td><td align="left" valign="top" rowspan="1" colspan="1">52.5 (14.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.110</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female sex, %</td><td align="left" valign="top" rowspan="1" colspan="1">45.1</td><td align="left" valign="top" rowspan="1" colspan="1">58.6</td><td align="left" valign="top" rowspan="1" colspan="1">74.3<xref rid="jdi13973-note-0003" ref-type="table-fn">**</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.002<xref rid="jdi13973-note-0002" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes duration, years</td><td align="left" valign="top" rowspan="1" colspan="1">14.9 (11.8)</td><td align="left" valign="top" rowspan="1" colspan="1">17.0 (12.9)</td><td align="left" valign="top" rowspan="1" colspan="1">17.3 (11.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.439</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Height, cm</td><td align="left" valign="top" rowspan="1" colspan="1">163.1 (9.6)</td><td align="left" valign="top" rowspan="1" colspan="1">162.8 (7.9)</td><td align="left" valign="top" rowspan="1" colspan="1">160.9 (7.9)</td><td align="char" valign="top" rowspan="1" colspan="1">0.271</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">22.7 (3.2)</td><td align="left" valign="top" rowspan="1" colspan="1">22.5 (2.9)</td><td align="left" valign="top" rowspan="1" colspan="1">23.2 (4.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.501</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#8805;25, %</td><td align="left" valign="top" rowspan="1" colspan="1">23.9</td><td align="left" valign="top" rowspan="1" colspan="1">17.1</td><td align="left" valign="top" rowspan="1" colspan="1">27.5</td><td align="char" valign="top" rowspan="1" colspan="1">0.331</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Blood pressure, mmHg</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Systolic</td><td align="left" valign="top" rowspan="1" colspan="1">126.7 (15.7)</td><td align="left" valign="top" rowspan="1" colspan="1">126.9 (14.8)</td><td align="left" valign="top" rowspan="1" colspan="1">124.4 (13.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.560</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diastolic</td><td align="left" valign="top" rowspan="1" colspan="1">71.7 (12.4)</td><td align="left" valign="top" rowspan="1" colspan="1">71.8 (11.1)</td><td align="left" valign="top" rowspan="1" colspan="1">70.9 (10.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.890</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Diabetic complication, %</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Peripheral neuropathy</td><td align="left" valign="top" rowspan="1" colspan="1">16.9</td><td align="left" valign="top" rowspan="1" colspan="1">17.6</td><td align="left" valign="top" rowspan="1" colspan="1">31.4</td><td align="char" valign="top" rowspan="1" colspan="1">0.076</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Retinopathy</td><td align="left" valign="top" rowspan="1" colspan="1">29.0</td><td align="left" valign="top" rowspan="1" colspan="1">24.6</td><td align="left" valign="top" rowspan="1" colspan="1">22.9</td><td align="char" valign="top" rowspan="1" colspan="1">0.719</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">NDR/SDR/PPDR/PDR</td><td align="left" valign="top" rowspan="1" colspan="1">71.0/17.4/1.4/10.1</td><td align="left" valign="top" rowspan="1" colspan="1">75.4/14.5/1.4/8.7</td><td align="left" valign="top" rowspan="1" colspan="1">77.1/14.3/0/8.6</td><td align="char" valign="top" rowspan="1" colspan="1">0.977</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Nephropathy</td><td align="left" valign="top" rowspan="1" colspan="1">14.3</td><td align="left" valign="top" rowspan="1" colspan="1">14.3</td><td align="left" valign="top" rowspan="1" colspan="1">17.1</td><td align="char" valign="top" rowspan="1" colspan="1">0.914</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1st/2nd/3rd/4th/5th</td><td align="left" valign="top" rowspan="1" colspan="1">85.7/8.6/2.9/0/2.9</td><td align="left" valign="top" rowspan="1" colspan="1">85.7/10.0/1.4/0/2.9</td><td align="left" valign="top" rowspan="1" colspan="1">82.9/11.4/5.7/0/0</td><td align="char" valign="top" rowspan="1" colspan="1">0.675</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Coronary artery disease, %</td><td align="left" valign="top" rowspan="1" colspan="1">4.2</td><td align="left" valign="top" rowspan="1" colspan="1">4.3</td><td align="left" valign="top" rowspan="1" colspan="1">4.3</td><td align="char" valign="top" rowspan="1" colspan="1">&gt;0.999</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cerebrovascular disease, %</td><td align="left" valign="top" rowspan="1" colspan="1">5.6</td><td align="left" valign="top" rowspan="1" colspan="1">4.3</td><td align="left" valign="top" rowspan="1" colspan="1">4.3</td><td align="char" valign="top" rowspan="1" colspan="1">&gt;0.999</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Severe hypoglycemia per 1 year, %</td><td align="left" valign="top" rowspan="1" colspan="1">10.0</td><td align="left" valign="top" rowspan="1" colspan="1">8.7</td><td align="left" valign="top" rowspan="1" colspan="1">14.5</td><td align="char" valign="top" rowspan="1" colspan="1">0.575</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Impaired awareness of hypoglycemia</td><td align="left" valign="top" rowspan="1" colspan="1">15.5</td><td align="left" valign="top" rowspan="1" colspan="1">13.0</td><td align="left" valign="top" rowspan="1" colspan="1">24.6</td><td align="char" valign="top" rowspan="1" colspan="1">0.183</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Diabetes treatment</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TDD</td><td align="left" valign="top" rowspan="1" colspan="1">33.2 (15.1)</td><td align="left" valign="top" rowspan="1" colspan="1">34.2 (14.6)</td><td align="left" valign="top" rowspan="1" colspan="1">34.6 (16.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.861</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TDD/BW</td><td align="left" valign="top" rowspan="1" colspan="1">0.55 (0.20)</td><td align="left" valign="top" rowspan="1" colspan="1">0.56 (0.19)</td><td align="left" valign="top" rowspan="1" colspan="1">0.57 (0.20)</td><td align="char" valign="top" rowspan="1" colspan="1">0.756</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Basal, %</td><td align="left" valign="top" rowspan="1" colspan="1">31.8 (12.8)</td><td align="left" valign="top" rowspan="1" colspan="1">35.1 (14.4)</td><td align="left" valign="top" rowspan="1" colspan="1">34.0 (14.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.354</td></tr></tbody></table><table-wrap-foot id="jdi13973-ntgp-0002"><fn id="jdi13973-note-0002"><label>*</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p></fn><fn id="jdi13973-note-0003"><label>**</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 (vs lowest tertile). BMI, body mass index; BW, body weight; NDR, no diabetic retinopathy; PDR, proliferative diabetic retinopathy; PPDR, pre&#8208;proliferative diabetic retinopathy; SDR, simple diabetic retinopathy; TDD, total daily dose of insulin.</p></fn></table-wrap-foot></table-wrap><sec id="jdi13973-sec-0012"><title>
<styled-content style="fixed-case" toggle="no">HGI</styled-content> and clinical characteristics</title><p>Figure&#160;<xref rid="jdi13973-fig-0001" ref-type="fig">1</xref> shows a histogram of HGI, the mean (standard deviation [SD]) and median (interquartile range [IQR]) in the total population were 0.7 (SD: 0.5) and 0.7 (IQR: 0.3, 1.0), respectively. The ratio of female sex showed increasing HGI from lower to higher tertiles (Table&#160;<xref rid="jdi13973-tbl-0001" ref-type="table">1</xref>). DPN tended to show increasing HGI from lower to higher tertiles. There was no difference in the severity of retinopathy and nephropathy among the HGI tertiles. The G&#8208;gap showed an increasing HGI from the lower to higher tertiles; however, there was no difference in the GA/HbA1c ratio among the groups. Factors associated with DPN were age (OR 1.06 [95% CI 1.03&#8211;1.08]), HbA1c (OR 1.52 [95% CI 1.06&#8211;2.19]), and HGI (OR 2.26 [95% CI 1.18&#8211;4.33]), but not BMI (OR, 1.01 [95% CI 0.92&#8211;1.11]). The HbA1c, GA, and G&#8208;gap values showed an increasing HGI from the lower to higher tertiles, although eGFR, Hb, MCH, and serum sodium levels decreased from the lower to higher tertiles (Table&#160;<xref rid="jdi13973-tbl-0002" ref-type="table">2</xref>). There were no differences in eating, exercise, lifestyle, or sleep habits among the subgroups (Table&#160;<xref rid="jdi13973-tbl-0003" ref-type="table">3</xref>). There was a significant correlation between HGI and HbA1c (<italic toggle="yes">r</italic>&#160;=&#160;0.596, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) and G&#8208;gap (<italic toggle="yes">r</italic>&#160;=&#160;0.310, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). However, age and BMI were not associated with HGI (<italic toggle="yes">r</italic>&#160;=&#160;0.124 and 0.096, <italic toggle="yes">P</italic>&#160;=&#160;0.073 and 0.168, respectively). There was no association between a low MCV and HbA1c in female subjects (<italic toggle="yes">P</italic>&#160;=&#160;0.914).</p><fig position="float" fig-type="Figure" id="jdi13973-fig-0001" orientation="portrait"><label>Figure 1</label><caption><p>Histogram of hemoglobin glycation index (HGI).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="JDI-14-582-g001.jpg"/></fig><table-wrap position="float" id="jdi13973-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Laboratory data of the study participants according to the HGI tertile</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Variable</th><th colspan="3" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">HGI tertile</th><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">
<italic toggle="yes">P</italic> value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Low (<italic toggle="yes">n</italic>&#160;=&#160;71)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Moderate (<italic toggle="yes">n</italic>&#160;=&#160;70)</th><th align="left" valign="bottom" rowspan="1" colspan="1">High (<italic toggle="yes">n</italic>&#160;=&#160;70)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">TP, g/dL</td><td align="left" valign="top" rowspan="1" colspan="1">7.0 (0.4)</td><td align="left" valign="top" rowspan="1" colspan="1">7.0 (0.4)</td><td align="left" valign="top" rowspan="1" colspan="1">6.9 (0.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.557</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alb, g/dL</td><td align="left" valign="top" rowspan="1" colspan="1">4.2 (0.4)</td><td align="left" valign="top" rowspan="1" colspan="1">4.2 (0.3)</td><td align="left" valign="top" rowspan="1" colspan="1">4.2 (0.3)</td><td align="char" valign="top" rowspan="1" colspan="1">0.905</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AST, U/L</td><td align="left" valign="top" rowspan="1" colspan="1">19.8 (6.4)</td><td align="left" valign="top" rowspan="1" colspan="1">21.5 (9.3)</td><td align="left" valign="top" rowspan="1" colspan="1">20.5 (7.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.459</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALT, U/L</td><td align="left" valign="top" rowspan="1" colspan="1">19.0 (10.9)</td><td align="left" valign="top" rowspan="1" colspan="1">18.3 (8.7)</td><td align="left" valign="top" rowspan="1" colspan="1">19.4 (11.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.826</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GGT, IU/L</td><td align="left" valign="top" rowspan="1" colspan="1">23.1 (18.6)</td><td align="left" valign="top" rowspan="1" colspan="1">21.7 (26.9)</td><td align="left" valign="top" rowspan="1" colspan="1">17.8 (9.9)</td><td align="char" valign="top" rowspan="1" colspan="1">0.283</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BUN, mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">15.8 (8.9)</td><td align="left" valign="top" rowspan="1" colspan="1">15.3 (4.3)</td><td align="left" valign="top" rowspan="1" colspan="1">16.7 (9.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.593</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">eGFR, mL/min per 1.73&#8201;m<sup>2</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">83.4 (21.3)</td><td align="left" valign="top" rowspan="1" colspan="1">75.6 (20.1)</td><td align="left" valign="top" rowspan="1" colspan="1">75.1 (19.4)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.029<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&lt;60 of eGFR</td><td align="left" valign="top" rowspan="1" colspan="1">5.8</td><td align="left" valign="top" rowspan="1" colspan="1">11.6</td><td align="left" valign="top" rowspan="1" colspan="1">19.1</td><td align="char" valign="top" rowspan="1" colspan="1">0.061<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1c, %</td><td align="left" valign="top" rowspan="1" colspan="1">7.0 (0.8)</td><td align="left" valign="top" rowspan="1" colspan="1">7.4 (0.7)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">8.2 (0.8)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>,<xref rid="jdi13973-note-0007" ref-type="table-fn">***</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GA, %</td><td align="left" valign="top" rowspan="1" colspan="1">20.1 (4.1)</td><td align="left" valign="top" rowspan="1" colspan="1">22.3 (4.1)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">23.4 (4.7)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.002<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GA/HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1">2.8 (0.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.9 (0.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.8 (0.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.390</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G&#8208;gap</td><td align="left" valign="top" rowspan="1" colspan="1">0.4 (0.7)</td><td align="left" valign="top" rowspan="1" colspan="1">0.4 (0.8)</td><td align="left" valign="top" rowspan="1" colspan="1">0.9 (0.7)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>,<xref rid="jdi13973-note-0007" ref-type="table-fn">***</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.005<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL&#8208;C, mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">101.2 (26.0)</td><td align="left" valign="top" rowspan="1" colspan="1">107.4 (28.4)</td><td align="left" valign="top" rowspan="1" colspan="1">110.0 (27.9)</td><td align="char" valign="top" rowspan="1" colspan="1">0.164</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL&#8208;C, mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">74.1 (22.5)</td><td align="left" valign="top" rowspan="1" colspan="1">77.2 (19.2)</td><td align="left" valign="top" rowspan="1" colspan="1">78.8 (20.9)</td><td align="char" valign="top" rowspan="1" colspan="1">0.413</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TG, mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">96.0 (57.0)</td><td align="left" valign="top" rowspan="1" colspan="1">99.9 (61.3)</td><td align="left" valign="top" rowspan="1" colspan="1">99.3 (76.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.932</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WBC, 10<sup>3</sup>/&#956;L</td><td align="left" valign="top" rowspan="1" colspan="1">5.6 (1.7)</td><td align="left" valign="top" rowspan="1" colspan="1">5.9 (2.3)</td><td align="left" valign="top" rowspan="1" colspan="1">5.9 (1.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.456</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RBC, 10<sup>6</sup>/&#956;L</td><td align="left" valign="top" rowspan="1" colspan="1">4.6 (0.5)</td><td align="left" valign="top" rowspan="1" colspan="1">4.5 (0.5)</td><td align="left" valign="top" rowspan="1" colspan="1">4.5 (0.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.456</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hb, g/dL</td><td align="left" valign="top" rowspan="1" colspan="1">13.9 (1.7)</td><td align="left" valign="top" rowspan="1" colspan="1">13.7 (1.3)</td><td align="left" valign="top" rowspan="1" colspan="1">13.2 (1.4)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.024<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&lt;11.0&#8201;g/dL, %</td><td align="left" valign="top" rowspan="1" colspan="1">4.2</td><td align="left" valign="top" rowspan="1" colspan="1">1.4</td><td align="left" valign="top" rowspan="1" colspan="1">4.3</td><td align="char" valign="top" rowspan="1" colspan="1">0.637</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MCV, fL</td><td align="left" valign="top" rowspan="1" colspan="1">91.6 (5.7)</td><td align="left" valign="top" rowspan="1" colspan="1">91.6 (4.0)</td><td align="left" valign="top" rowspan="1" colspan="1">89.9 (5.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.097</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MCH, pg</td><td align="left" valign="top" rowspan="1" colspan="1">30.4 (2.2)</td><td align="left" valign="top" rowspan="1" colspan="1">30.4 (1.5)</td><td align="left" valign="top" rowspan="1" colspan="1">29.6 (2.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.036<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MCHC, %</td><td align="left" valign="top" rowspan="1" colspan="1">33.2 (1.1)</td><td align="left" valign="top" rowspan="1" colspan="1">33.2 (0.8)</td><td align="left" valign="top" rowspan="1" colspan="1">32.9 (1.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.105</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Na, mEq/L</td><td align="left" valign="top" rowspan="1" colspan="1">140.0 (2.3)</td><td align="left" valign="top" rowspan="1" colspan="1">139.6 (2.5)</td><td align="left" valign="top" rowspan="1" colspan="1">138.9 (1.9)<xref rid="jdi13973-note-0006" ref-type="table-fn">**</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.023<xref rid="jdi13973-note-0005" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">K, mEq/L</td><td align="left" valign="top" rowspan="1" colspan="1">4.2 (0.4)</td><td align="left" valign="top" rowspan="1" colspan="1">4.2 (0.4)</td><td align="left" valign="top" rowspan="1" colspan="1">4.3 (0.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.106</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cl, mEq/L</td><td align="left" valign="top" rowspan="1" colspan="1">103.6 (2.3)</td><td align="left" valign="top" rowspan="1" colspan="1">103.5 (2.8)</td><td align="left" valign="top" rowspan="1" colspan="1">103.1 (2.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.698</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Osmolarity, mOsm/L</td><td align="left" valign="top" rowspan="1" colspan="1">294.2 (6.0)</td><td align="left" valign="top" rowspan="1" colspan="1">293.0 (5.6)</td><td align="left" valign="top" rowspan="1" colspan="1">292.2 (4.8)</td><td align="char" valign="top" rowspan="1" colspan="1">0.177</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NLR</td><td align="left" valign="top" rowspan="1" colspan="1">2.4 (2.3)</td><td align="left" valign="top" rowspan="1" colspan="1">2.2 (0.9)</td><td align="left" valign="top" rowspan="1" colspan="1">2.2 (1.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.805</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PLR</td><td align="left" valign="top" rowspan="1" colspan="1">9.4 (6.4)</td><td align="left" valign="top" rowspan="1" colspan="1">8.3 (3.3)</td><td align="left" valign="top" rowspan="1" colspan="1">8.9 (4.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.697</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fibrosis&#8208;4 index</td><td align="left" valign="top" rowspan="1" colspan="1">1.0 (0.6)</td><td align="left" valign="top" rowspan="1" colspan="1">1.2 (0.7)</td><td align="left" valign="top" rowspan="1" colspan="1">1.2 (0.6)</td><td align="char" valign="top" rowspan="1" colspan="1">0.128</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#8805;1.3 of FIB4 index, %</td><td align="left" valign="top" rowspan="1" colspan="1">22.7</td><td align="left" valign="top" rowspan="1" colspan="1">34.8</td><td align="left" valign="top" rowspan="1" colspan="1">31.2</td><td align="char" valign="top" rowspan="1" colspan="1">0.287</td></tr></tbody></table><table-wrap-foot id="jdi13973-ntgp-0003"><fn id="jdi13973-note-0004"><p>Mean (SD).</p></fn><fn id="jdi13973-note-0005"><label>*</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p></fn><fn id="jdi13973-note-0006"><label>**</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 (vs lowest tertile).</p></fn><fn id="jdi13973-note-0007"><label>***</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 (vs moderate tertile). Alb, albumin; ALT, alanine transaminase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; G&#8208;gap, Glycation gap; GGT, gamma&#8208;glutamyl transferase; HbA1c, glycated hemoglobin; HDL&#8208;C, high&#8208;density lipoprotein cholesterol; LDL&#8208;C, low&#8208;density lipoprotein cholesterol; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; NLR, neutrophil&#8208;to&#8208;lymphocyte ratio; PLR, platelet&#8208;to&#8208;lymphocyte ratio; RBC, red blood cell; TG, triglyceride; TP, total protein; WBC, white blood cell.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jdi13973-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Lifestyle factors of the participants according to the HGI tertile</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Variable</th><th colspan="3" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">HGI tertile</th><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">
<italic toggle="yes">P</italic> value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Low (<italic toggle="yes">n</italic>&#160;=&#160;71)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Moderate (<italic toggle="yes">n</italic>&#160;=&#160;70)</th><th align="left" valign="bottom" rowspan="1" colspan="1">High (<italic toggle="yes">n</italic>&#160;=&#160;70)</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="5" valign="top" rowspan="1">Eating habits, %</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Skipping breakfast</td><td align="left" valign="top" rowspan="1" colspan="1">12.7</td><td align="left" valign="top" rowspan="1" colspan="1">13.0</td><td align="left" valign="top" rowspan="1" colspan="1">7.1</td><td align="char" valign="top" rowspan="1" colspan="1">0.471</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Fast eating</td><td align="left" valign="top" rowspan="1" colspan="1">28.2</td><td align="left" valign="top" rowspan="1" colspan="1">36.2</td><td align="left" valign="top" rowspan="1" colspan="1">31.4</td><td align="char" valign="top" rowspan="1" colspan="1">0.605</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Late&#8208;night dinner eating</td><td align="left" valign="top" rowspan="1" colspan="1">26.8</td><td align="left" valign="top" rowspan="1" colspan="1">29.0</td><td align="left" valign="top" rowspan="1" colspan="1">24.3</td><td align="char" valign="top" rowspan="1" colspan="1">0.836</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Snack and sweetened beverage</td><td align="left" valign="top" rowspan="1" colspan="1">70.0</td><td align="left" valign="top" rowspan="1" colspan="1">72.5</td><td align="left" valign="top" rowspan="1" colspan="1">69.6</td><td align="char" valign="top" rowspan="1" colspan="1">0.945</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Fruits &#8805;1 intake per day</td><td align="left" valign="top" rowspan="1" colspan="1">22.5</td><td align="left" valign="top" rowspan="1" colspan="1">36.2</td><td align="left" valign="top" rowspan="1" colspan="1">31.4</td><td align="char" valign="top" rowspan="1" colspan="1">0.194</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Milk &#8805;1 intake per day</td><td align="left" valign="top" rowspan="1" colspan="1">60.6</td><td align="left" valign="top" rowspan="1" colspan="1">65.2</td><td align="left" valign="top" rowspan="1" colspan="1">75.7</td><td align="char" valign="top" rowspan="1" colspan="1">0.144</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Vegetable &#8805;5 dishes intake per day</td><td align="left" valign="top" rowspan="1" colspan="1">4.2</td><td align="left" valign="top" rowspan="1" colspan="1">2.9</td><td align="left" valign="top" rowspan="1" colspan="1">2.9</td><td align="char" valign="top" rowspan="1" colspan="1">&gt;0.999</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Exercise habit, %</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Exercise</td><td align="left" valign="top" rowspan="1" colspan="1">35.2</td><td align="left" valign="top" rowspan="1" colspan="1">33.3</td><td align="left" valign="top" rowspan="1" colspan="1">35.7</td><td align="char" valign="top" rowspan="1" colspan="1">0.966</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Physical activity</td><td align="left" valign="top" rowspan="1" colspan="1">60.6</td><td align="left" valign="top" rowspan="1" colspan="1">62.3</td><td align="left" valign="top" rowspan="1" colspan="1">62.9</td><td align="char" valign="top" rowspan="1" colspan="1">0.968</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Fast walking</td><td align="left" valign="top" rowspan="1" colspan="1">39.4</td><td align="left" valign="top" rowspan="1" colspan="1">43.5</td><td align="left" valign="top" rowspan="1" colspan="1">52.9</td><td align="char" valign="top" rowspan="1" colspan="1">0.265</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Lifestyle factors, %</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Overwork</td><td align="left" valign="top" rowspan="1" colspan="1">19.7</td><td align="left" valign="top" rowspan="1" colspan="1">21.7</td><td align="left" valign="top" rowspan="1" colspan="1">11.4</td><td align="char" valign="top" rowspan="1" colspan="1">0.247</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Current smoking</td><td align="left" valign="top" rowspan="1" colspan="1">12.7</td><td align="left" valign="top" rowspan="1" colspan="1">7.2</td><td align="left" valign="top" rowspan="1" colspan="1">7.1</td><td align="char" valign="top" rowspan="1" colspan="1">0.477</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Drinking everyday</td><td align="left" valign="top" rowspan="1" colspan="1">21.1</td><td align="left" valign="top" rowspan="1" colspan="1">26.1</td><td align="left" valign="top" rowspan="1" colspan="1">15.7</td><td align="char" valign="top" rowspan="1" colspan="1">0.330</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Excessive drinking</td><td align="left" valign="top" rowspan="1" colspan="1">12.7</td><td align="left" valign="top" rowspan="1" colspan="1">14.5</td><td align="left" valign="top" rowspan="1" colspan="1">10.0</td><td align="char" valign="top" rowspan="1" colspan="1">0.727</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Sleep habits, min</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Average sleep time</td><td align="left" valign="top" rowspan="1" colspan="1">397 (68)</td><td align="left" valign="top" rowspan="1" colspan="1">401 (58)</td><td align="left" valign="top" rowspan="1" colspan="1">397 (55)</td><td align="char" valign="top" rowspan="1" colspan="1">0.910</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sleep time in weekday</td><td align="left" valign="top" rowspan="1" colspan="1">381 (75)</td><td align="left" valign="top" rowspan="1" colspan="1">390 (61)</td><td align="left" valign="top" rowspan="1" colspan="1">387 (62)</td><td align="char" valign="top" rowspan="1" colspan="1">0.690</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sleep time in weekend</td><td align="left" valign="top" rowspan="1" colspan="1">439 (76)</td><td align="left" valign="top" rowspan="1" colspan="1">428 (74)</td><td align="left" valign="top" rowspan="1" colspan="1">424 (63)</td><td align="char" valign="top" rowspan="1" colspan="1">0.459</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sleep debt, %</td><td align="left" valign="top" rowspan="1" colspan="1">26.8</td><td align="left" valign="top" rowspan="1" colspan="1">15.9</td><td align="left" valign="top" rowspan="1" colspan="1">17.1</td><td align="char" valign="top" rowspan="1" colspan="1">0.241</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Non&#8208;restorative sleep, %</td><td align="left" valign="top" rowspan="1" colspan="1">32.9</td><td align="left" valign="top" rowspan="1" colspan="1">20.3</td><td align="left" valign="top" rowspan="1" colspan="1">27.1</td><td align="char" valign="top" rowspan="1" colspan="1">0.251</td></tr></tbody></table></table-wrap></sec><sec id="jdi13973-sec-0013"><title>
<styled-content style="fixed-case" toggle="no">HGI</styled-content> tertiles and <styled-content style="fixed-case" toggle="no">CGM</styled-content> metrics</title><p>The average daily risk range (ADRR) and CV showed an increasing HGI from the lower to higher tertiles. There was no difference in SD, MAGE, HBGI, LBGI, and MODD among the HGI tertiles (Table&#160;<xref rid="jdi13973-tbl-0004" ref-type="table">4</xref>). As shown in Table&#160;<xref rid="jdi13973-tbl-0005" ref-type="table">5</xref>, multivariate linear regression analysis identified female sex, HbA1c, CV, and eGFR as factors that could influence the HGI (<italic toggle="yes">R</italic>
<sup>2</sup>&#160;=&#160;0.44, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). In a stepwise multivariate analysis, female sex (&#946;&#160;=&#160;0.221, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), HbA1c (&#946;&#160;=&#160;0.331, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), %CV (&#946;&#160;=&#160;0.012, <italic toggle="yes">P</italic>&#160;=&#160;0.007), and eGFR (&#946;&#160;=&#160;&#8722;0.003, <italic toggle="yes">P</italic>&#160;=&#160;0.018) were associated with HGI (<italic toggle="yes">R</italic>
<sup>2</sup>&#160;=&#160;0.44, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). There was no difference in the mean absolute relative difference (MARD) between the groups.</p><table-wrap position="float" id="jdi13973-tbl-0004" content-type="Table" orientation="portrait"><label>Table 4</label><caption><p>CGM metrics of the participants according to the HGI tertile</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Variable</th><th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">HGI tertile</th><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">
<italic toggle="yes">P</italic> value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Low (<italic toggle="yes">n</italic>&#160;=&#160;71)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Moderate (<italic toggle="yes">n</italic>&#160;=&#160;70)</th><th align="left" valign="bottom" rowspan="1" colspan="1">High (<italic toggle="yes">n</italic>&#160;=&#160;70)</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="5" valign="top" rowspan="1">Average glucose, mg/dL</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">90&#8201;days</td><td align="char" valign="top" rowspan="1" colspan="1">149.8 (34.3)</td><td align="char" valign="top" rowspan="1" colspan="1">144.9 (27.3)</td><td align="char" valign="top" rowspan="1" colspan="1">151.2 (30.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.443</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Recent 14&#8201;days</td><td align="char" valign="top" rowspan="1" colspan="1">147.5 (35.6)</td><td align="char" valign="top" rowspan="1" colspan="1">144.4 (29.3)</td><td align="char" valign="top" rowspan="1" colspan="1">152.8 (34.3)</td><td align="char" valign="top" rowspan="1" colspan="1">0.323</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GMI, %</td><td align="char" valign="top" rowspan="1" colspan="1">6.9 (0.8)</td><td align="char" valign="top" rowspan="1" colspan="1">6.8 (0.7)</td><td align="char" valign="top" rowspan="1" colspan="1">6.9 (0.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.443</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">TAR, %</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&gt;250&#8201;mg/dL</td><td align="char" valign="top" rowspan="1" colspan="1">8.3 (10.4)</td><td align="char" valign="top" rowspan="1" colspan="1">6.8 (6.6)</td><td align="char" valign="top" rowspan="1" colspan="1">8.9 (9.3)</td><td align="char" valign="top" rowspan="1" colspan="1">0.354</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&gt;180&#8201;mg/dL</td><td align="char" valign="top" rowspan="1" colspan="1">28.3 (18.1)</td><td align="char" valign="top" rowspan="1" colspan="1">26.6 (14.7)</td><td align="char" valign="top" rowspan="1" colspan="1">30.0 (16.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.462</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TIR, %</td><td align="char" valign="top" rowspan="1" colspan="1">63.3 (15.2)</td><td align="char" valign="top" rowspan="1" colspan="1">62.7 (12.6)</td><td align="char" valign="top" rowspan="1" colspan="1">60.0 (13.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.330</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">TBR, %</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&lt;70&#8201;mg/dL</td><td align="char" valign="top" rowspan="1" colspan="1">8.4 (9.4)</td><td align="char" valign="top" rowspan="1" colspan="1">10.7 (10.2)</td><td align="char" valign="top" rowspan="1" colspan="1">10.0 (8.0)</td><td align="char" valign="top" rowspan="1" colspan="1">0.301</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&lt;54&#8201;mg/dL</td><td align="char" valign="top" rowspan="1" colspan="1">3.0 (4.3)</td><td align="char" valign="top" rowspan="1" colspan="1">5.0 (7.0)</td><td align="char" valign="top" rowspan="1" colspan="1">4.5 (4.9)</td><td align="char" valign="top" rowspan="1" colspan="1">0.081</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Glycemic variability</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">ADRR</td><td align="char" valign="top" rowspan="1" colspan="1">38.7 (9.8)</td><td align="char" valign="top" rowspan="1" colspan="1">41.4 (11.1)</td><td align="char" valign="top" rowspan="1" colspan="1">43.5 (10.9)<xref rid="jdi13973-note-0009" ref-type="table-fn">**</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.031<xref rid="jdi13973-note-0008" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">%CV</td><td align="char" valign="top" rowspan="1" colspan="1">32.6 (5.1)</td><td align="char" valign="top" rowspan="1" colspan="1">34.8 (6.7)</td><td align="char" valign="top" rowspan="1" colspan="1">35.0 (5.9)<xref rid="jdi13973-note-0009" ref-type="table-fn">**</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.029<xref rid="jdi13973-note-0008" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MAGE</td><td align="char" valign="top" rowspan="1" colspan="1">13.9 (6.3)</td><td align="char" valign="top" rowspan="1" colspan="1">13.6 (7.5)</td><td align="char" valign="top" rowspan="1" colspan="1">12.2 (5.7)</td><td align="char" valign="top" rowspan="1" colspan="1">0.261</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">HBGI</td><td align="char" valign="top" rowspan="1" colspan="1">6.5 (5.0)</td><td align="char" valign="top" rowspan="1" colspan="1">5.9 (3.5)</td><td align="char" valign="top" rowspan="1" colspan="1">6.9 (4.4)</td><td align="char" valign="top" rowspan="1" colspan="1">0.405</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">LBGI</td><td align="char" valign="top" rowspan="1" colspan="1">2.0 (2.2)</td><td align="char" valign="top" rowspan="1" colspan="1">2.8 (2.8)</td><td align="char" valign="top" rowspan="1" colspan="1">2.5 (2.1)</td><td align="char" valign="top" rowspan="1" colspan="1">0.190</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td><td align="char" valign="top" rowspan="1" colspan="1">56.1 (14.6)</td><td align="char" valign="top" rowspan="1" colspan="1">57.8 (14.2)</td><td align="char" valign="top" rowspan="1" colspan="1">60.9 (14.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.142</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MODD</td><td align="char" valign="top" rowspan="1" colspan="1">74.1 (28.0)</td><td align="char" valign="top" rowspan="1" colspan="1">77.6 (28.4)</td><td align="char" valign="top" rowspan="1" colspan="1">78.8 (26.5)</td><td align="char" valign="top" rowspan="1" colspan="1">0.578</td></tr></tbody></table><table-wrap-foot id="jdi13973-ntgp-0004"><fn id="jdi13973-note-0008"><label>*</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p></fn><fn id="jdi13973-note-0009"><label>**</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 (vs lowest tertile). ADRR, average daily risk range; GMI, glucose management indicator; HBGI, high blood glucose index; LBGI, low blood glucose index; MAGE, mean amplitude of glycemic excursions; MOOD, mean of daily differences; SD, standard deviation; TAR, time&#8208;above&#8208;range; TBR, time&#8208;below&#8208;range; TIR, time&#8208;in&#8208;range.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jdi13973-tbl-0005" content-type="Table" orientation="portrait"><label>Table 5</label><caption><p>Association variables with HGI</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="center" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Variable</th><th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Univariate analysis</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Multivariate analysis</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">&#946;</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">R</italic>
<sup>2</sup>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th><th align="left" valign="bottom" rowspan="1" colspan="1">&#946;</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">R</italic>
<sup>2</sup>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th><th align="left" valign="bottom" rowspan="1" colspan="1">VIF</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Female sex</td><td align="char" valign="top" rowspan="1" colspan="1">0.289</td><td align="char" valign="top" rowspan="1" colspan="1">0.070</td><td align="char" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.181</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1">0.008<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">1.488</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1c</td><td align="char" valign="top" rowspan="1" colspan="1">0.339</td><td align="char" valign="top" rowspan="1" colspan="1">0.353</td><td align="char" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.334</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">1.020</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">%CV</td><td align="char" valign="top" rowspan="1" colspan="1">0.012</td><td align="char" valign="top" rowspan="1" colspan="1">0.015</td><td align="char" valign="top" rowspan="1" colspan="1">0.044<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">0.012</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.44</td><td align="char" valign="top" rowspan="1" colspan="1">0.012<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">1.026</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">eGFR</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.004</td><td align="char" valign="top" rowspan="1" colspan="1">0.020</td><td align="char" valign="top" rowspan="1" colspan="1">0.024<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.003</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1">0.026<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">1.019</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hb</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.067</td><td align="char" valign="top" rowspan="1" colspan="1">0.033</td><td align="char" valign="top" rowspan="1" colspan="1">0.005<xref rid="jdi13973-note-0010" ref-type="table-fn">*</xref>
</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.024</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1">0.284</td><td align="char" valign="top" rowspan="1" colspan="1">1.519</td></tr></tbody></table><table-wrap-foot id="jdi13973-ntgp-0005"><fn id="jdi13973-note-0010"><label>*</label><p>
<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05. CV, coefficient of variation; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; VIF, variance inflation factor.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="jdi13973-sec-0014"><title>DISCUSSION</title><p>This is the first study to examine the association of HGI with diabetic complications and CGM metrics in Japanese adults with type 1 diabetes. In this study, a high HGI was significantly associated with female sex, as reported previously in people with a high risk of diabetes<xref rid="jdi13973-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="jdi13973-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>. The relationship between HGI and female sex was consistent across studies. The etiology of sex differences in HGI could be explained by heritable differences in erythrocyte lifespans<xref rid="jdi13973-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> and glucose transport<xref rid="jdi13973-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>.</p><sec id="jdi13973-sec-0015"><title>Association of <styled-content style="fixed-case" toggle="no">HGI</styled-content> with <styled-content style="fixed-case" toggle="no">GV</styled-content> and G&#8208;gap</title><p>Glycemic variability is an important metric to be considered when assessing glycemic control in clinical practice<xref rid="jdi13973-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>. In this study, the most popular metrics of GV (%CV and ADRR) showed a significant increase over the HGI tertiles. Liu <italic toggle="yes">et al</italic>.<xref rid="jdi13973-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> reported that GV influenced the relationship between GMI measured using the iPro&#8482;2 sensor and laboratory HbA1c in 91 adults with type 1 diabetes. This study indicated the association between HGI and G&#8208;gap, which is an index of intracellular glycation of proteins. A small study of 36 patients with type 2 diabetes identified a strong correlation between the mean blood glucose (MBG) HGI and G&#8208;gap<xref rid="jdi13973-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>. In this study, eGFR was negatively associated with HGI.</p></sec><sec id="jdi13973-sec-0016"><title>
<styled-content style="fixed-case" toggle="no">HGI</styled-content> and <styled-content style="fixed-case" toggle="no">DPN</styled-content>
</title><p>This study shows an association between the HGI and DPN. In 1,441 people with type 1 diabetes, a high HGI based on MBG was associated with an increased risk of nephropathy and retinopathy, but the study did not check the association between HGI and neuropathy<xref rid="jdi13973-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>. There were no differences in age, diabetes duration, unhealthy lifestyle (smoking, excessive alcohol consumption, and low physical activity), lifestyle&#8208;related disease (hypertension and dyslipidemia), and subclinical inflammation markers among groups. However, several risk factors for DPN have been reported in previous studies<xref rid="jdi13973-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>. Bragd <italic toggle="yes">et al</italic>.<xref rid="jdi13973-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> indicated that blood GV might be an important risk factor for the development of peripheral neuropathy in patients with type 1 diabetes, but another study based on SMBG did not confirm this association<xref rid="jdi13973-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref>. In a recent study from Korea and China, GV in CGM was independently associated with the presence of neuropathy in patients with type 2 diabetes<xref rid="jdi13973-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>, <xref rid="jdi13973-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>. In contrast, HGI was inversely associated with peripheral nerve conduction velocity (NCV) in 324 patients with type 2 diabetes<xref rid="jdi13973-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref>. However, NCV was not measured in this study. Since the role of the HGI in DPN remains unclear, reducing the HGI could become an important part of diabetes management, and its association with DPN should be established. Further examination including the measurement of NCV and reduction of HGI intervention, is required to confirm these issues in adults with type 1 diabetes in the future.</p></sec><sec id="jdi13973-sec-0017"><title>Clinical implications</title><p>The hemoglobin glycation index has been proposed as a marker for quantifying inter&#8208;individual variation in Hb glycosylation. There are several formulas for HGI: FPG&#8208;<xref rid="jdi13973-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>, <xref rid="jdi13973-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, MBG&#8208;, and CGM&#8208;based. MBG&#8208; or CGM&#8208;based HGI are often used for patients with type 1 diabetes, while FBG&#8208;based HGI are often used for the general population or patients with type 2 diabetes. A meta&#8208;analysis indicated that a high FBG&#8208;based HGI was associated with an increased risk of cardiovascular disease and mortality in people with type 2 diabetes<xref rid="jdi13973-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>. FBG&#8208;based HGI is useful for hyperglycemia diagnosis in high&#8208;risk patients or patients with type 2 diabetes because HGI reflects the difference between FBG and the estimated average glucose derived from HbA1c. The association of HGI with morbidity and mortality might be mainly mediated by the level of HbA1c. Conversely, for MBG&#8208;based HGI, a seven&#8208;sample glucose profile (before and after three main meals and bedtime), is an index of between&#8208;individual differences in HbA1c adjusted for glycemia. However, it is difficult for patients with type 1 diabetes or type 2 diabetes to measure seven&#8208;sample glucose every day in routine clinical practice. In recent decades, CGM technology has become increasingly popular and offers a variety of metrics. In this study, we adopted a CGM&#8208;based HGI, which is relatively accurate, and the study indicated that a high HGI was associated with DPN and ADRR, a measure of hypo&#8208; and hyperglycemic risk. Careful attention should be paid to type 1 diabetes adults with high HGI as a potential risk, although the underlying mechanism is unclear.</p></sec><sec id="jdi13973-sec-0018"><title>Strength and limitations</title><p>The strength of this study is its long&#8208;term CGM&#8208;based data providing an ambulatory glucose profile. This study has several limitations, including its cross&#8208;sectional design. We did not measure AGE, labile A1c<xref rid="jdi13973-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref>, or fructosamine. The concept of G&#8208;gap using fructosamine proposed by Cohen <italic toggle="yes">et al</italic>.<xref rid="jdi13973-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> was widely used for examining the association of G&#8208;gap and diabetic complications. On the other hand, GA is another index for the evaluation of glycemia, which might be better compared with HbA1c and fructosamine. The main component of fructosamine is GA, but fructosamine contains other components such as glycated lipoprotein and glycated globulin. Recently, G&#8208;gap using GA has been used for diabetes research<xref rid="jdi13973-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>. GA was routinely measured as a glycemic control marker in people with type 1 diabetes and gestational diabetes in Japan<xref rid="jdi13973-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>. Then, we adopted G&#8208;gap using GA in this study. Some reports have shown that black participants have a higher HGI, independent of their diabetes status<xref rid="jdi13973-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>. Whether Japanese individuals have a higher HGI is unknown. The generalizability of the results is limited by the target population (Japanese adults with type 1 diabetes). There are several conditions under which the HbA1c test can produce inaccurate results because of falsely low and high values<xref rid="jdi13973-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>. There was no difference in the prevalence of anemia, diabetic nephropathy, FIB4 index, or excessive alcohol consumption, affecting falsely low HbA1c values among the groups. However, a falsely high HbA1c level can be due to iron deficiency anemia and hypertriglyceridemia. The absolute value of the correlation indicated the coefficient of determination. The HGI was moderately explained using HbA1c, with a moderate coefficient of determination (<italic toggle="yes">R</italic>
<sup>2</sup>&#160;=&#160;0.39). Iron storage depletion is usually identified by serum ferritin levels, but we did not measure serum ferritin in this study. Then, we adopted the mean corpuscular volume (MCV). Iron deficiency is the most common cause of microcytic anemia, which is defined as the presence of small red characterized by a low MCV (&lt;83&#8201;fL)<xref rid="jdi13973-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>. There was no association between a low MCV and HbA1c in females. The algorithm of glucose measurement by an intermittent&#8208;scanning continuous glucose monitoring (isCGM) device has been improved recently. Therefore, further examination including the isCGM device with a new algorithm (third generation) and the serum ferritin are required to confirm these issues.</p><p>In conclusion, HGI is associated with female sex, DPN renal function, and some GV indices. The HGI calculated from CGM data is considered a convenient measurable indicator to assess the inter&#8208;individual variation of HbA1c in the present era of CGM technology. Standardizing how the HGI is calculated would normalize the results between research studies and hospital laboratories and facilitate the clinical use of the HGI for assessing risk<xref rid="jdi13973-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="jdi13973-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>. This information will help diabetic healthcare professionals and patients to personalize the management of glycemic control in adults with type 1 diabetes. However, the coefficient of determination (<italic toggle="yes">R</italic>
<sup>2</sup>&#160;=&#160;0.44) was less than half, and other factors influencing the HGI should be considered. Further examination, including the biokinetic model and other factors, is required to investigate the underlying mechanism of increasing HGI.</p></sec></sec><sec id="jdi13973-sec-0020"><title>DISCLOSURE</title><p>The authors declare no conflict of interest.</p><p>Approval of the research protocol: The present study was approved by the ethics committee of the National Hospital Organization Kyoto Medical Center (No. 19&#8208;072). This study conformed to the standards of the Declaration of Helsinki.</p><p>Informed consent: Informed consent or a substitute for it to be included in the study was obtained from all patients.</p><p>Registry and the registration no. of the study/trial: Trial registration number: University hospital Medical Information Network (UMIN) Center: UMIN000039376.</p><p>Animal studies: N/A.</p></sec></body><back><ack id="jdi13973-sec-0019"><title>ACKNOWLEDGMENTS</title><p>The authors are grateful to RN Yukiko Tsuchida (Tokyo Women's Medical University). This work is supported by the FGM&#8208;study Diabetology group. The FGM&#8208;Japan study was completed with funding from the Japan Agency for Medical Research and Development (AMED) (Grant number: 18ek0210104h0001, 19ek0210104h0002, 20ek0210104h0003) and Japan.</p></ack><ref-list content-type="cited-references" id="jdi13973-bibl-0001"><title>REFERENCES</title><ref id="jdi13973-bib-0001"><label>1</label><mixed-citation publication-type="book" id="jdi13973-cit-0001"><string-name name-style="western"><surname>Eyth</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Naik</surname><given-names>R</given-names></string-name>. <part-title>Hemoglobin A1C</part-title>. In: <source>StatPearls [Internet]</source>. <publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>, <year>2022</year>.<pub-id pub-id-type="pmid">31747223</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jdi13973-cit-0002"><string-name name-style="western"><surname>Hempe</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Standardizing the haemoglobin glycation index</article-title>. <source>Endocrinol Diabetes Metab</source><year>2021</year>; <volume>4</volume>: <elocation-id>e00299</elocation-id>. Erratum in: <italic toggle="yes">Endocrinol Diabetes Metab</italic> 2022; 5: e00322.<pub-id pub-id-type="pmid">34558807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/edm2.299</pub-id><pub-id pub-id-type="pmcid">PMC8502217</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jdi13973-cit-0003"><string-name name-style="western"><surname>Wu</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>Y</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Association between hemoglobin glycation index and risk of cardiovascular disease and all cause mortality in type 2 diabetic patients: A&#160;meta&#8208;analysis</article-title>. <source>Front Cardiovasc Med</source><year>2021</year>; <volume>8</volume>: <elocation-id>690689</elocation-id>.<pub-id pub-id-type="pmid">34124211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcvm.2021.690689</pub-id><pub-id pub-id-type="pmcid">PMC8193090</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jdi13973-cit-0004"><string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>R</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Hemoglobin glycation index in relationship to the risk of cardiovascular complication in patients with type 2 diabetes: A systematic review and meta&#8208;analysis</article-title>. <source>J Diabetes Complications</source><year>2020</year>; <volume>34</volume>: <elocation-id>107673</elocation-id>.<pub-id pub-id-type="pmid">32768332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jdiacomp.2020.107673</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jdi13973-cit-0005"><string-name name-style="western"><surname>&#216;stergaard</surname><given-names>HB</given-names></string-name>, <string-name name-style="western"><surname>Mandrup&#8208;Poulsen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Berkelmans</surname><given-names>GFN</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients</article-title>. <source>Diabetes Metab</source><year>2019</year>; <volume>45</volume>: <fpage>254</fpage>&#8211;<lpage>260</lpage>.<pub-id pub-id-type="pmid">29784563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.diabet.2018.04.006</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jdi13973-cit-0006"><string-name name-style="western"><surname>van Steen</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Schrieks</surname><given-names>IC</given-names></string-name>, <string-name name-style="western"><surname>Hoekstra</surname><given-names>JB</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>The haemoglobin glycation index as predictor of diabetes&#8208;related complications in the AleCardio trial</article-title>. <source>Eur J Prev Cardiol</source><year>2017</year>; <volume>24</volume>: <fpage>858</fpage>&#8211;<lpage>866</lpage>.<pub-id pub-id-type="pmid">28186441</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2047487317692664</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jdi13973-cit-0007"><string-name name-style="western"><surname>Leslie</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Cohen</surname><given-names>RM</given-names></string-name>. <article-title>Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications</article-title>. <source>J Diabetes Sci Technol</source><year>2009</year>; <volume>3</volume>: <fpage>635</fpage>&#8211;<lpage>643</lpage>.<pub-id pub-id-type="pmid">20144305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/193229680900300403</pub-id><pub-id pub-id-type="pmcid">PMC2769979</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jdi13973-cit-0008"><string-name name-style="western"><surname>Nagayama</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Watanabe</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yamaguchi</surname><given-names>T</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>High hemoglobin glycation index is associated with increased systemic arterial stiffness independent of hyperglycemia in real&#8208;world Japanese population: A cross&#8208;sectional study</article-title>. <source>Diab Vasc Dis Res</source><year>2020</year>; <volume>17</volume>: <elocation-id>1479164120958625</elocation-id>.<pub-id pub-id-type="pmid">32985267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1479164120958625</pub-id><pub-id pub-id-type="pmcid">PMC7919210</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jdi13973-cit-0009"><string-name name-style="western"><surname>Kim</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Go</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>DR</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10&#8208;year longitudinal cohort study</article-title>. <source>J Diabetes Complications</source><year>2021</year>; <volume>35</volume>: <elocation-id>107760</elocation-id>.<pub-id pub-id-type="pmid">33077349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jdiacomp.2020.107760</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jdi13973-cit-0010"><string-name name-style="western"><surname>Mi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Association of hemoglobin glycation index and its interaction with obesity/family history of hypertension on hypertension risk: A community&#8208;based cross&#8208;sectional survey</article-title>. <source>BMC Cardiovasc Disord</source><year>2020</year>; <volume>20</volume>: <fpage>477</fpage>.<pub-id pub-id-type="pmid">33148181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12872-020-01762-0</pub-id><pub-id pub-id-type="pmcid">PMC7640660</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jdi13973-cit-0011"><string-name name-style="western"><surname>Soros</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Chalew</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>McCarter</surname><given-names>RJ</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Hemoglobin glycation index: A robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients</article-title>. <source>Pediatr Diabetes</source><year>2010</year>; <volume>11</volume>: <fpage>455</fpage>&#8211;<lpage>461</lpage>.<pub-id pub-id-type="pmid">20088859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1399-5448.2009.00630.x</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jdi13973-cit-0012"><string-name name-style="western"><surname>Hempe</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Gomez</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>McCarter</surname><given-names>RJ</given-names><suffix>Jr</suffix></string-name>, <italic toggle="yes">et al</italic>. <article-title>High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic control</article-title>. <source>J Diabetes Complications</source><year>2002</year>; <volume>16</volume>: <fpage>313</fpage>&#8211;<lpage>320</lpage>.<pub-id pub-id-type="pmid">12200073</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1056-8727(01)00227-6</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jdi13973-cit-0013"><string-name name-style="western"><surname>McCarter</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Hempe</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Gomez</surname><given-names>R</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes</article-title>. <source>Diabetes Care</source><year>2004</year>; <volume>27</volume>: <fpage>1259</fpage>&#8211;<lpage>1264</lpage>.<pub-id pub-id-type="pmid">15161772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diacare.27.6.1259</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jdi13973-cit-0014"><string-name name-style="western"><surname>Lachin</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Genuth</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nathan</surname><given-names>DM</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial</article-title>. <source>Diabetes</source><year>2007</year>; <volume>56</volume>: <fpage>1913</fpage>&#8211;<lpage>1921</lpage>.<pub-id pub-id-type="pmid">17360979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db07-0028</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jdi13973-cit-0015"><string-name name-style="western"><surname>Chalew</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hempe</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>McCarter</surname><given-names>R</given-names></string-name>. <article-title>Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913&#8211;1921, 2007</article-title>. <source>Diabetes</source><year>2008</year>; <volume>57</volume>: <elocation-id>e4</elocation-id>; author reply e5.<pub-id pub-id-type="pmid">18227521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db07-1569</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jdi13973-cit-0016"><string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hempe</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>McCarter</surname><given-names>RJ</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Association between inflammation and biological variation in hemoglobin A1c in U.S. nondiabetic adults</article-title>. <source>J Clin Endocrinol Metab</source><year>2015</year>; <volume>100</volume>: <fpage>2364</fpage>&#8211;<lpage>2371</lpage>.<pub-id pub-id-type="pmid">25867810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/jc.2014-4454</pub-id><pub-id pub-id-type="pmcid">PMC4454807</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jdi13973-cit-0017"><string-name name-style="western"><surname>Lyu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>High hemoglobin glycation index is associated with telomere attrition independent of HbA1c, mediated by TNF&#945;</article-title>. <source>J Clin Endocrinol Metab</source><year>2022</year>; <volume>107</volume>: <fpage>462</fpage>&#8211;<lpage>473</lpage>.<pub-id pub-id-type="pmid">34562085</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/clinem/dgab703</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jdi13973-cit-0018"><string-name name-style="western"><surname>Kovatchev</surname><given-names>BP</given-names></string-name>, <string-name name-style="western"><surname>Otto</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cox</surname><given-names>D</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Evaluation of a new measure of blood glucose variability in diabetes</article-title>. <source>Diabetes Care</source><year>2006</year>; <volume>29</volume>: <fpage>2433</fpage>&#8211;<lpage>2438</lpage>.<pub-id pub-id-type="pmid">17065680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc06-1085</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jdi13973-cit-0019"><string-name name-style="western"><surname>McDonnell</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Donath</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Vidmar</surname><given-names>SI</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>A novel approach to continuous glucose analysis utilizing glycemic variation</article-title>. <source>Diabetes Technol Ther</source><year>2005</year>; <volume>7</volume>: <fpage>253</fpage>&#8211;<lpage>263</lpage>.<pub-id pub-id-type="pmid">15857227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/dia.2005.7.253</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jdi13973-cit-0020"><string-name name-style="western"><surname>Chehregosha</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Khamseh</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Malek</surname><given-names>M</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>A view beyond HbA1c: Role of continuous glucose monitoring</article-title>. <source>Diabetes Ther</source><year>2019</year>; <volume>10</volume>: <fpage>853</fpage>&#8211;<lpage>863</lpage>.<pub-id pub-id-type="pmid">31037553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13300-019-0619-1</pub-id><pub-id pub-id-type="pmcid">PMC6531520</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jdi13973-cit-0021"><string-name name-style="western"><surname>Danne</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Nimri</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Battelino</surname><given-names>T</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>International consensus on use of continuous glucose monitoring</article-title>. <source>Diabetes Care</source><year>2017</year>; <volume>40</volume>: <fpage>1631</fpage>&#8211;<lpage>1640</lpage>.<pub-id pub-id-type="pmid">29162583</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc17-1600</pub-id><pub-id pub-id-type="pmcid">PMC6467165</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jdi13973-cit-0022"><string-name name-style="western"><surname>Furuichi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Shimizu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hara</surname><given-names>A</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Diabetic nephropathy: A comparison of the clinical and pathological features between the CKD risk classification and the classification of diabetic nephropathy 2014 in Japan</article-title>. <source>Intern Med</source><year>2018</year>; <volume>57</volume>: <fpage>3345</fpage>&#8211;<lpage>3350</lpage>.<pub-id pub-id-type="pmid">30101924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2169/internalmedicine.1132-18</pub-id><pub-id pub-id-type="pmcid">PMC6306527</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jdi13973-cit-0023"><string-name name-style="western"><surname>Himeno</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kamiya</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Nakamura</surname><given-names>J</given-names></string-name>. <article-title>Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions</article-title>. <source>J Diabetes Investig</source><year>2020</year>; <volume>11</volume>: <fpage>5</fpage>&#8211;<lpage>16</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jdi.13173</pub-id><pub-id pub-id-type="pmcid">PMC6944828</pub-id><pub-id pub-id-type="pmid">31677343</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0024"><label>24</label><mixed-citation publication-type="book" id="jdi13973-cit-0024"><string-name name-style="western"><surname>Sarma</surname><given-names>PR</given-names></string-name>. <part-title>Chapter 152. Red cell indices</part-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Walker</surname><given-names>HK</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Hall</surname><given-names>WD</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Hurst</surname><given-names>JW</given-names></string-name></person-group> (eds). <source>Clinical Methods: The History, Physical, and Laboratory Examinations</source>, <edition designator="3">3rd edn</edition>. <publisher-loc>Boston</publisher-loc>: <publisher-name>Butterworths</publisher-name>, <year>1990</year>.<pub-id pub-id-type="pmid">21250045</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jdi13973-cit-0025"><string-name name-style="western"><surname>Bhagat</surname><given-names>CI</given-names></string-name>, <string-name name-style="western"><surname>Garcia&#8208;Webb</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Fletcher</surname><given-names>E</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Calculated vs measured plasma osmolalities revisited</article-title>. <source>Clin Chem</source><year>1984</year>; <volume>30</volume>: <fpage>1703</fpage>&#8211;<lpage>1705</lpage>.<pub-id pub-id-type="pmid">6537784</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jdi13973-cit-0026"><string-name name-style="western"><surname>Ogawa</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hayashi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kishihara</surname><given-names>E</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>New indices for predicting glycaemic variability</article-title>. <source>PLoS One</source><year>2012</year>; <volume>7</volume>: <elocation-id>e46517</elocation-id>.<pub-id pub-id-type="pmid">23029543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0046517</pub-id><pub-id pub-id-type="pmcid">PMC3459933</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jdi13973-cit-0027"><string-name name-style="western"><surname>Kim</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Jeong</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Kwon</surname><given-names>HS</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes</article-title>. <source>J Diabetes Complications</source><year>2017</year>; <volume>31</volume>: <fpage>1127</fpage>&#8211;<lpage>1131</lpage>.<pub-id pub-id-type="pmid">28487124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jdiacomp.2017.04.015</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jdi13973-cit-0028"><string-name name-style="western"><surname>Paleari</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Strollo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Guerra</surname><given-names>E</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Glycation gap: An additional tool for glycometabolic monitoring</article-title>. <source>Clin Chim Acta</source><year>2016</year>; <volume>463</volume>: <fpage>27</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="pmid">27720725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cca.2016.10.004</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jdi13973-cit-0029"><string-name name-style="western"><surname>DiGangi</surname><given-names>C</given-names></string-name>. <article-title>Neutrophil&#8208;lymphocyte ratio: Predicting cardiovascular and renal complications in patients with diabetes</article-title>. <source>J Am Assoc Nurse Pract</source><year>2016</year>; <volume>28</volume>: <fpage>410</fpage>&#8211;<lpage>414</lpage>.<pub-id pub-id-type="pmid">27092809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/2327-6924.12366</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jdi13973-cit-0030"><string-name name-style="western"><surname>Saito</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Tanabe</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kudo</surname><given-names>A</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes</article-title>. <source>Sci Rep</source><year>2021</year>; <volume>11</volume>: <elocation-id>11753</elocation-id>.<pub-id pub-id-type="pmid">34083571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-88285-6</pub-id><pub-id pub-id-type="pmcid">PMC8175689</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jdi13973-cit-0031"><string-name name-style="western"><surname>Fukasawa</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Tanemura</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kimura</surname><given-names>S</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Utility of a specific health checkup database containing lifestyle behaviors and lifestyle diseases for employee health Insurance in Japan</article-title>. <source>J Epidemiol</source><year>2020</year>; <volume>30</volume>: <fpage>57</fpage>&#8211;<lpage>66</lpage>.<pub-id pub-id-type="pmid">30828034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2188/jea.JE20180192</pub-id><pub-id pub-id-type="pmcid">PMC6949185</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jdi13973-cit-0032"><string-name name-style="western"><surname>Kordowski</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>K&#252;nstner</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Schweitzer</surname><given-names>L</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Palatinose&#8482; (Isomaltulose) and prebiotic inulin&#8208;type Fructans have beneficial effects on glycemic response and gut microbiota composition in healthy volunteers&#8208;a real&#8208;life, retrospective study of a cohort that participated in a digital nutrition program</article-title>. <source>Front Nutr</source><year>2022</year>; <volume>9</volume>: <elocation-id>829933</elocation-id>.<pub-id pub-id-type="pmid">35340549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnut.2022.829933</pub-id><pub-id pub-id-type="pmcid">PMC8948463</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jdi13973-cit-0033"><string-name name-style="western"><surname>Broll</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Urbanek</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Buchanan</surname><given-names>D</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Interpreting blood GLUcose data with R package iglu</article-title>. <source>PLoS One</source><year>2021</year>; <volume>16</volume>: <elocation-id>e0248560</elocation-id>.<pub-id pub-id-type="pmid">33793578</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0248560</pub-id><pub-id pub-id-type="pmcid">PMC8016265</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jdi13973-cit-0034"><string-name name-style="western"><surname>Hsia</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Rasouli</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Pittas</surname><given-names>AG</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Implications of the hemoglobin glycation index on the diagnosis of prediabetes and diabetes</article-title>. <source>J Clin Endocrinol Metab</source><year>2020</year>; <volume>105</volume>: <fpage>e130</fpage>&#8211;<lpage>e138</lpage>.<pub-id pub-id-type="pmid">31965161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/clinem/dgaa029</pub-id><pub-id pub-id-type="pmcid">PMC7015453</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jdi13973-cit-0035"><string-name name-style="western"><surname>Stimson</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Dover</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Forbes</surname><given-names>S</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>HbA1c is disproportionately higher in women and older people with type 1 diabetes compared with flash glucose monitoring metrics of glycemic control</article-title>. <source>J Diabetes Sci Technol</source><year>2022</year>; <volume>16</volume>: <fpage>446</fpage>&#8211;<lpage>453</lpage>.<pub-id pub-id-type="pmid">33100062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1932296820967335</pub-id><pub-id pub-id-type="pmcid">PMC8861792</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jdi13973-cit-0036"><string-name name-style="western"><surname>Cohen</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Franco</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Khera</surname><given-names>PK</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c</article-title>. <source>Blood</source><year>2008</year>; <volume>112</volume>: <fpage>4284</fpage>&#8211;<lpage>4291</lpage>.<pub-id pub-id-type="pmid">18694998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2008-04-154112</pub-id><pub-id pub-id-type="pmcid">PMC2581997</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jdi13973-cit-0037"><string-name name-style="western"><surname>Khera</surname><given-names>PK</given-names></string-name>, <string-name name-style="western"><surname>Joiner</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Carruthers</surname><given-names>A</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation</article-title>. <source>Diabetes</source><year>2008</year>; <volume>57</volume>: <fpage>2445</fpage>&#8211;<lpage>2452</lpage>.<pub-id pub-id-type="pmid">18591386</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db07-1820</pub-id><pub-id pub-id-type="pmcid">PMC2518496</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jdi13973-cit-0038"><string-name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>S</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Glycemic variability: Adverse clinical outcomes and how to improve it?</article-title><source>Cardiovasc Diabetol</source><year>2020</year>; <volume>19</volume>: <fpage>102</fpage>.<pub-id pub-id-type="pmid">32622354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12933-020-01085-6</pub-id><pub-id pub-id-type="pmcid">PMC7335439</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jdi13973-cit-0039"><string-name name-style="western"><surname>Liu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>H</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Impacts of glycemic variability on the relationship between glucose management indicator from iPro&#8482;2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitus</article-title>. <source>Ther Adv Endocrinol Metab</source><year>2020</year>; <volume>11</volume>: <elocation-id>2042018820931664</elocation-id>.<pub-id pub-id-type="pmid">32551036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2042018820931664</pub-id><pub-id pub-id-type="pmcid">PMC7281639</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jdi13973-cit-0040"><string-name name-style="western"><surname>Joung</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Kwon</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Baek</surname><given-names>KH</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Consistency of the glycation gap with the hemoglobin glycation index derived from a continuous glucose monitoring system</article-title>. <source>Endocrinol Metab (Seoul)</source><year>2020</year>; <volume>35</volume>: <fpage>377</fpage>&#8211;<lpage>383</lpage>.<pub-id pub-id-type="pmid">32615722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3803/EnM.2020.35.2.377</pub-id><pub-id pub-id-type="pmcid">PMC7386126</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jdi13973-cit-0041"><string-name name-style="western"><surname>Papanas</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ziegler</surname><given-names>D</given-names></string-name>. <article-title>Risk factors and comorbidities in diabetic neuropathy: An update 2015</article-title>. <source>Rev Diabet Stud</source><year>2015</year>; <volume>12</volume>: <fpage>48</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="pmid">26676661</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1900/RDS.2015.12.48</pub-id><pub-id pub-id-type="pmcid">PMC5397983</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jdi13973-cit-0042"><string-name name-style="western"><surname>Bragd</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Adamson</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>B&#228;cklund</surname><given-names>LB</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Can glycaemic variability, as calculated from blood glucose self&#8208;monitoring, predict the development of complications in type 1 diabetes over a decade?</article-title><source>Diabetes Metab</source><year>2008</year>; <volume>34</volume>: <fpage>612</fpage>&#8211;<lpage>616</lpage>.<pub-id pub-id-type="pmid">18824382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.diabet.2008.04.005</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jdi13973-cit-0043"><string-name name-style="western"><surname>Siegelaar</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Kilpatrick</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Rigby</surname><given-names>AS</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: Data from the DCCT</article-title>. <source>Diabetologia</source><year>2009</year>; <volume>52</volume>: <fpage>2229</fpage>&#8211;<lpage>2232</lpage>.<pub-id pub-id-type="pmid">19672575</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00125-009-1473-x</pub-id><pub-id pub-id-type="pmcid">PMC2744825</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jdi13973-cit-0044"><string-name name-style="western"><surname>Jun</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Jin</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Baek</surname><given-names>J</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes</article-title>. <source>Cardiovasc Diabetol</source><year>2015</year>; <volume>14</volume>: <fpage>70</fpage>.<pub-id pub-id-type="pmid">26041130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12933-015-0233-0</pub-id><pub-id pub-id-type="pmcid">PMC4462181</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="jdi13973-cit-0045"><string-name name-style="western"><surname>Xu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>JB</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well&#8208;controlled HbA1c</article-title>. <source>Diabetol Metab Syndr</source><year>2014</year>; <volume>6</volume>: <elocation-id>139</elocation-id>.<pub-id pub-id-type="pmid">25530811</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1758-5996-6-139</pub-id><pub-id pub-id-type="pmcid">PMC4272789</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="jdi13973-cit-0046"><string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>Y</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Correlation between hemoglobin glycosylation index and nerve conduction velocity in patients with type 2 diabetes mellitus</article-title>. <source>Diabetes Metab Syndr Obes</source><year>2021</year>; <volume>14</volume>: <fpage>4757</fpage>&#8211;<lpage>4765</lpage>.<pub-id pub-id-type="pmid">34887673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/DMSO.S334767</pub-id><pub-id pub-id-type="pmcid">PMC8653709</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="jdi13973-cit-0047"><string-name name-style="western"><surname>Klein</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Franek</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Marso</surname><given-names>S</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE</article-title>. <source>BMJ Open Diabetes Res Care</source><year>2021</year>; <volume>9</volume>: <elocation-id>e002339</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjdrc-2021-002339</pub-id><pub-id pub-id-type="pmcid">PMC8614152</pub-id><pub-id pub-id-type="pmid">34819298</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="jdi13973-cit-0048"><string-name name-style="western"><surname>Hempe</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Myers</surname><given-names>L</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial</article-title>. <source>Diabetes Care</source><year>2015</year>; <volume>38</volume>: <fpage>1067</fpage>&#8211;<lpage>1074</lpage>.<pub-id pub-id-type="pmid">25887355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc14-1844</pub-id><pub-id pub-id-type="pmcid">PMC4439529</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="jdi13973-cit-0049"><string-name name-style="western"><surname>Chalew</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>McCarter</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Ory&#8208;Ascani</surname><given-names>J</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes</article-title>. <source>Diabetes Care</source><year>2010</year>; <volume>33</volume>: <fpage>273</fpage>&#8211;<lpage>274</lpage>.<pub-id pub-id-type="pmid">19918006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc08-2220</pub-id><pub-id pub-id-type="pmcid">PMC2809262</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="jdi13973-cit-0050"><string-name name-style="western"><surname>Cohen</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Holmes</surname><given-names>YR</given-names></string-name>, <string-name name-style="western"><surname>Chenier</surname><given-names>TC</given-names></string-name>, <italic toggle="yes">et al</italic>. <article-title>Discordance between HbA1c and fructosamine: Evidence for a glycosylation gap and its relation to diabetic nephropathy</article-title>. <source>Diabetes Care</source><year>2003</year>; <volume>26</volume>: <fpage>163</fpage>&#8211;<lpage>167</lpage>.<pub-id pub-id-type="pmid">12502674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diacare.26.1.163</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="jdi13973-cit-0051"><string-name name-style="western"><surname>Koga</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kasayama</surname><given-names>S</given-names></string-name>. <article-title>Clinical impact of glycated albumin as another glycemic control marker</article-title>. <source>Endocr J</source><year>2010</year>; <volume>57</volume>: <fpage>751</fpage>&#8211;<lpage>762</lpage>.<pub-id pub-id-type="pmid">20724796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1507/endocrj.k10e-138</pub-id></mixed-citation></ref><ref id="jdi13973-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="jdi13973-cit-0052"><string-name name-style="western"><surname>Massey</surname><given-names>AC</given-names></string-name>. <article-title>Microcytic anemia. Differential diagnosis and management of iron deficiency anemia</article-title>. <source>Med Clin North Am</source><year>1992</year>; <volume>76</volume>: <fpage>549</fpage>&#8211;<lpage>566</lpage>.<pub-id pub-id-type="pmid">1578956</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0025-7125(16)30339-x</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>